The Kill Switch Was a Phone Call
Two frontier models left the market without a published technical finding, and the mechanism that removed them is available to any competitor holding a regulatory relationship.
The bar that was cleared is the problem
The technique cited in the revocation was a prompt asking the model to read a codebase and fix its flaws. It surfaced a handful of minor, already-known vulnerabilities. Anthropic's public position is that GPT-5.5 does the same work with no bypass at all. Whatever the merits, an enforcement bar that low is repeatable — and it was cleared by researchers at a company that is simultaneously Anthropic's distribution partner and its competitor. POLITICO's account has Amazon researchers testing the model two days after its June 9 release, Andy Jassy phoning the White House, and the Commerce letter arriving after Dario Amodei refused to pull the model.
Strip out the AI specifics and the structure is familiar to anyone who has run a platform business: a partner who also competes used a regulatory channel to remove a rival's product, with no published finding and no appeal path.
Model access stopped being a procurement decision and became a political exposure — and most enterprises are still single-sourced.
Read the scope, not the headline
Two details matter more than the letter itself. First, the removal was surgical: other models in the family were untouched, so this was not a vendor outage, a breach, or a capacity decision. Second, it reached Anthropic's own foreign-national employees, inside and outside the United States. Your standard continuity language — uptime credits, support tiers, escalation paths — covers none of that. The event your contract does not describe is precisely the one that happened.
Where the reporting agrees, and where it splits
Across the available coverage the agreement is unanimous on direction: single-lab dependency is now a regulatory exposure, not merely a commercial one. The Information's reporting supplies the mirror image. Anthropic publicly accused several Chinese labs of using Claude illicitly and routing sensitive domestic data into it, and within days China's internet regulator opened an investigation into DeepSeek and Moonshot AI. No lawsuit, no injunction — a vendor published what its telemetry showed and a foreign regulator did the punishing. Compliance disclosure is now a market-share instrument, and it runs in both directions.
The split is in what you do about it. Benedict Evans frames vendor risk as substitutability: quantify switching cost per workload, and pre-agree what Anthropic's year-end S-1 would have to show — margin after distribution payments, stock comp, customer concentration — to change your build/buy stance. The Commerce thread frames it as continuity: advance notification, service credits on government-ordered suspension, export-control contingency, disclosure of foreign-national access restrictions. Those are different clauses drafted by different people. You need both, and only one of them is in anyone's template.
The move
Fund portability as a resilience line item and frame it to the board as supply continuity rather than engineering elegance, because the scenario you are insuring against is a letter, not an outage. In practice that means a model-agnostic abstraction layer with a maintained eval harness — the harness is the expensive half, and without it a switch is a guess rather than a decision. Then do the cheap part nobody has done: write down which of your investors, resellers and distribution partners also compete with you at the model layer, and what regulatory relationships they hold. That list is short, it takes a week, and it is the difference between a supplier map and an escalation map.
What to do
Commission a 30-day model-portability audit mapping every revenue-critical workload to its model dependency, with a named owner and a tested switch runbook per workload.
Add regulatory-continuity terms to every frontier-model agreement at the next renewal: advance notification, service credits on government-ordered suspension, and written disclosure of foreign-national access restrictions.
Map every investor, reseller and distribution partner that also competes at the model layer, and brief the board this quarter on which relationships are escalation channels.